drugset / Trial / NCT01502969

Safety and Immunogenicity Assessment of Rotavin-M1 in Vietnamese Children

NCT01502969 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

This is a multiple-site phase 2b, randomized, placebo control study to evaluate the safety and immunogenicity of Rotavin-M1, produced by the Center for Research and Production of Vaccines and Biologicals, Vietnam.

Timeline

Start
2010-05
Primary completion
2011-09
Completion
2011-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator ROTAVIN-M1 Vaccine 1e+06 unknown —

Indications